| abstract |
The present invention relates to formula (I): (Wherein,-L-is -C (= X) -, etc., -Z- is -NR 5 -, etc., -Z A - is -NR 5A - like, -W- is, -C (R 8 R 9 ) N-, -W A -is -C (R 3 R 4 ) m-, B is a substituted or unsubstituted aromatic carbocyclic group, Y is a single bond, etc., ring C is substituted or unsubstituted An aromatic heterocyclic ring, R 2 is a hydrogen atom, etc.) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition containing them. |